Midwest Vision Research Foundation

Summary

Midwest Vision Research Foundation is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Retinal Disease, None and other specialties. Midwest Vision Research Foundation is involved with conducting 17 clinical trials across 20 conditions. There are 1 research doctors associated with this hospital, such as Mujtaba Qazi, M.D..

Top PIs

Clinical Trials running at Midwest Vision Research Foundation

Age-Related Macular Degeneration

Macular Degeneration

Choroidal Neovascularization

Retinal Degeneration

Retinal Disease

None

Choroidal neovascularization

Wet AMD

Diabetic Macular Edema

Neurotrophic Keratopathy

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

PDS Implant with Ranibizumab

for Age-Related Macular Degeneration

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.

Recruiting

2 awards

Phase 3

3 criteria